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Background: Free radicals-induced neurodegeneration is one of the many causes of Parkinson’s disease (PD).
This study investigated the neuroprotective effects of flavonol isoquercitrin against toxicity induced by 6-hydroxy-
dopamine (6-OHDA) in rat pheochromocytoma (PC12) cells.
Methods: PC12 cells were pretreated with different concentrations of isoquercitrin for 4, 8 and 12 hours and
incubated with 6-OHDA for 24 hours to induce oxidative cell damage.
Results: A significant cytoprotective activity was observed in isoquercitrin pre-treated cells in a dose-dependent
manner. There was a significant increase (P < 0.01) in the antioxidant enzymes namely superoxide dismutase,
catalase, glutathione peroxidase, and glutathione in isoquercitrin pretreated cells compared to cells incubated with
6-OHDA alone. Isoquercitrin significantly reduced (P < 0.01) lipid peroxidation in 6-OHDA treated cells. These results
suggested that isoquercitrin protects PC 12 cells against 6-OHDA–induced oxidative stress.
Conclusions: The present study suggests the protective role of isoquercitrin on 6-hydroxydopamine-induced toxicity
by virtue of its antioxidant potential. Isoquercitrin could be a potential therapeutic agent against neurodegeneration in
Parkinson’s disease.
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Parkinson’s disease (PD) is a neurodegenerative disease in-
volving the degeneration of dopaminergic neurons in the
striatum. The selective loss of dopaminergic neurons in
the substantia nigra is the primary neuropathology in PD
[1-3]. One of the many causes of PD is the accumulation
of free radicals and oxidative stress which leads to the se-
lective neuronal loss [4-6]. Though great advances have
been made in the development of novel drugs to treat this
disease, the appropriate pharmacological agent for PD is
still elusive [3,7]. Alternative therapy in PD is aimed to ef-
fectively prevent the progression of neurodegeneration
process hence improving the clinical presentation of PD
including tremor, bradykinesia, rigor and hypokinesia [8].
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distribution, and reproduction in any mediumhelpful in prolonging the survival of dopaminergic neu-
rons. Flavonoids are naturally occurring polyphenol com-
pounds widely distributed throughout the plant kingdom
[9,10]. They exhibit a variety of biological activities, such
as anti-oxidation, anti-inflammation, anti-bacteria, and
anti-allergy [11-14]. Many of these flavonoids act as neu-
roprotective agents in many neurological disorders [4,15].
Isoquercitrin, also known as quercetin 3-glucoside, is
a glucose-bound derivative of quercetin, and is reported
to have anti-inflammatory and antioxidant activities [5,6].
Isoquercitrin is widely found in mangoes, rheum nobile,
apples, onions and in many other fruits and vegetables
[16,17]. It is considered to be a “bio-quercetin” without
the potential adverse effect of quercetin [18]. Although
several studies have demonstrated the antioxidant prop-
erty of isoquercitrin [5,6,16,17], but the neuroprotective
potential of isoquercitrin is not well explored. Hence, the
objectives of our study are to establish the neuroprotective
role of isoquercitrin as well as to elucidate the antioxidantntral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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toxicity in PC12 neuronal cells. PC12 cells are commonly
used in the investigation of neurotherapeutics study for
Parkinson’s disease. These cells are known to secrete dopa-
mine neurotransmitter and contain high amounts of dopa-
mine transporters. The cell line is derived from the rat
pheochromocytoma and is frequently used as an in vitro
model to study neuronal toxicities of drugs on central
dopaminergic neurons [19,20].
Results
Dose response of 6-OHDA toxicity
The effect of different concentrations of 6-OHDA was
assessed on 10,000 cells/well to determine the concentra-
tion of 6-OHDA which results in 50% of cell inhibition
(IC50 value). The results showed a significant decline of cell
viability following 24 hours of incubation of PC12 cells with
an increasing concentration of 6-OHDA (0 – 200 μM). The
6-OHDA concentration which resulted in 50% PC12 cell
inhibition was 100 μM (50.33 ± 1.72) compared to the nega-
tive control group. The mean percentage of cell viability of
each group was compared with the mean percentage of un-
treated control and reported as mean ± SEM (Figure 1).
Evidence of isoquercitrin in protecting 6-OHDA- induced
oxidative stress
Isoquercitrin pre-treatment showed a significant increase
in cell viability compared to cells treated with 6-OHDA
alone. The 100 μM of 6-OHDA alone resulted in cell via-
bility of 50.80 ± 1.66. The cell viability was the highest at
10 μM of isoquercitrin at all the three durations of time.
However, the optimum reading was recorded at 10 μM of
isoquercitrin at 8 hours of pretreatment (73.2 ± 1.01) withFigure 1 The dose–response of different concentrations of 6-hydroxydo
in 1 × 105 cells/well. Pheochromocytoma (PC 12) cells for the duration of 24
assay. Values are the percentages of viable cells, with the viability of untreated
independent experiments (n = 4). **p < 0.01, relative to untreated cells.p < 0.001. The cell viability was also high as the cells ex-
posed for longer durations with isoquercitrin which is at
12 hours (Figure 2). These findings suggest that isoquerci-
trin could activate the native antioxidant mechanisms in
the PC12 cells during the pretreatment phase, which was
able to protect these cells from undergoing neurodegener-
ation process.
Glutathione
The glutathione level was significantly higher in the un-
treated sample and lower in samples incubated with
6-OHDA alone (p < 0.001). All samples incubated with
isoquercitrin demonstrated higher amount of glutathione
concentrations (p < 0.001). The glutathione concentration
was indirectly proportional to the isoquercitrin concentra-
tions. Isoquercitrin pretreatment at 10 μM, showed the
highest glutathione concentration in all pretreatment du-
rations (4, 8 and 12 hours) with p < 0.05 relative to 6-
OHDA treated group (Figure 3). However, the level of total
glutathione was very much decreased at 100 μM of iso-
quercitrin at 8 and 12 hour of pretreatment compared to
the 4 hours of pretreatment.
Glutathione peroxidase
The GPx enzyme level was significantly higher in isoquer-
citrin pretreated samples compared to the sample incu-
bated with 6-OHDA alone (p < 0.001). The enzyme activity
increased in a dose dependent manner and the highest ac-
tivity was found at 100 μM of isoquercitrin pre-treated at 8
and 12 hours of incubation period. (p < 0.05 and p < 0.01).
However, isoquercitrin did not stimulate the GPx activity
at concentrations lower than 100 μM at all pretreatment
periods as shown in Figure 4.pamine (6-OHDA) (0–200 μM) used to induce neurodegeneration
h. The viability of PC12 cells was determined using the MTT reduction
control cells taken as 100%. Data are mean and S.E. values from three
Figure 2 Assessment of cell viability after pretreatment with isoquercitrin. The isoquercitrin pre - treatment showed a significant increase in
cell viability compared to cells treated with 6-OHDA alone. The cell viability was the highest at 10 μM of isoquercitrin at all the three durations of
time. Cell viability increased as the cells exposed for 12 hrs. with isoquercitrin. Values are the percentages of viable cells, with the viability of
untreated control cells (control) taken as 100%. Data are mean and S.E. values from three independent experiments (n = 3). #p < 0.05, relative to
control cells. *p < 0.05, **p < 0.01 and ***p < 0.001, relative to cells treated only with 6-OHDA.
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The superoxide dismutase level was significantly increased
(p < 0.01) in all isoquercitrin pretreated PC12 cells. The
SOD activity did not change to a greater level as the dur-
ation of exposure with isoquercitrin was increased. How-
ever, the assay showed statistically significant elevation of
SOD activity with the presence of isoquercitrin in a dose-
dependent manner (p < 0.01) (Figure 5).
Catalase
Isoquercitrin showed a significant increase (p < 0.01) in
catalase activity in all pretreated cells in a dose dependentFigure 3 Effect of isoquercitrin on glutathione level. There are significa
samples incubated with 6-OHDA. The isoquercitrin pretreatment increased
and S.E. values from three independent experiments (n = 3). #p < 0.05, relat
with 6-OHDA.pattern. Isoquercitrin pretreated PC12 cells showed a
marked increase in catalase activity in a dose-dependent
manner as shown in Figure 6. The highest catalase activity
was observed at 100 μM of isoquercitrin at 4, 8 and 12
hours of pretreatments. Therefore, we can suggest that
catalase enzymes was greatly suppressed during oxidative
stress (6-OHDA alone) and markedly expressed in the
presence of isoquercitrin (Figure 6).
Lipid peroxidation
A significant reduction of malondialdehyde level was ob-
served in cells treated with isoquercitrin. PC12 cells treatedntly higher glutathione in the control sample and significantly lower in
the glutathione level in 6-OHDA induced PC12 cells. Data are mean
ive to control cells. *p < 0.05, relative to cells treated only
Figure 4 Effect of isoquercitrin on glutathione peroxidase activity. The enzyme level was significantly higher in isoquercitrin pretreated
samples. Glutathione peroxidase activity increased in a dose dependent manner. Data are mean and S.E. values from three independent
experiments (n = 3). #p < 0.05, relative to control cells. *p < 0.05 and **p < 0.01, relative to cells treated only with 6-OHDA.
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malondialdehyde which is an indication of lipid peroxida-
tion or oxidative stress. Isoquercitrin significantly reduced
the lipid peroxidation in a dose-dependent manner. The
highest concentration of isoquercitrin showed the greatest
potential in suppressing lipid peroxidation in PC12 cells as
the MDA level was the least in that group (100 μM). All
the test groups displayed significant results with p < 0.01
relative to 6-OHDA treated cells alone (Figure 7).
Discussion
Many lines of evidence have proven the oxidative stress
due to imbalance in the free radical generation and en-
dogenous antioxidant defense system may lead to the se-
lective neuronal loss in Parkinson’s disease [21-23]. Hence,
flavonoid polyphenols, particularly isoquercitrin can be an
ideal candidate as neuroprotective agent to cease or delayFigure 5 Effect of isoquercitrin on superoxide dismutase activity. The
was a significant elevation of SOD with the presence of isoquercitrin in a d
independent experiments (n = 3). #p < 0.001, relative to control cells. *p < 0
with 6-OHDA.the degeneration of dopaminergic cells [24,25]. In our
study, the neuroprotective role of isoquercitrin, a flavonoid
glycoside was investigated using a 6-OHDA induced PC12
cellular model of Parkinson’s disease. In the cell viability
assay, isoquercitrin pretreatment has demonstrated a
remarkable increase of cell viability at 12 hours of in-
cubation with 10 μM of isoquercitrin. The isoquercitrin
pretreated prior to 6-OHDA exposure resulted in stimula-
tion of antioxidant enzyme activity in the neuronal cells
as the cells are more resilient in coping with upcoming
oxidative stress [26,27]. The antioxidant enzyme defense
system functions in eliminating the free radical induced
cellular damage during the defense against microorgan-
isms, toxic chemicals and other conditions of cellular
stress [20,21,28].
To further validate the neuroprotective role of iso-
quercitrin, the antioxidant enzyme status of isoquercitrinSOD significantly increased in all isoquercitrin pretreated cells. There
ose-dependent manner. Data are mean and S.E. values from three
.05, **p < 0.01 and ***p < 0.001, relative to cells treated only
Figure 6 Effect of isoquercitrin on catalase activity. Isoquercitrin showed a significant increase in the catalase activity in all pretreated cells in
a dose dependent pattern. The greater activity of catalase was seen after 4 and 12 hours. Data are mean and S.E. values from three independent
experiments (n = 3). #p < 0.01, relative to control cells.*p < 0.05, **p < 0.01 and ***p < 0.001, relative to cells treated only with 6-OHDA.
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dant capability of this flavonol. The antioxidant enzymes
which were studied are superoxide dismutase (SOD), cata-
lase (CAT), glutathione and glutathione peroxidase (GPx).
SOD occur in significantly higher amounts in the brain
and these enzymes, which are of three types (Cu-Zn SOD,
Mn-SOD and EC-SOD) readily catalyze the dismutation of
the superoxide anion to oxygen molecules and hydrogen
peroxide, a less toxic molecule [21,29]. There was a signifi-
cant increase in SOD in all the isoquercitrin pretreated
cells in a dose dependent manner. This increase in SOD
activity proved that there was a direct activation of SOD
by isoquercitrin to catalyze the superoxide anions pro-
duced by 6-OHDA. Catalase, a tetrameric structure with
four indistinguishable tetrahedrally arranged residues withFigure 7 Effect of isoquercitrin on lipid peroxidation. Isoquercitrin sign
The highest concentration of isoquercitrin showed the greatest potential in
values from three independent experiments (n = 3). #p < 0.01, relative to co
with 6-OHDA.a single ferri-protoporphyrin subunit is ubiquitously found
in the liver, kidney and erythrocytes [30]. Catalase ac-
counts for detoxifying H2O2 molecules, whereby it is con-
verted to oxygen and water molecule and this reaction
through a reaction known as the catalytic reaction [31].
The CAT activity in isoquercitrin pretreated 6-OHDA in-
duced PC12 cells showed a statistically significant effect in
all the treatment groups. The CAT activity in the 6-OHDA
treated group was significantly reduced compared to con-
trol group. The increased CAT activity could be due to
two mechanisms, (i) increased in hydrogen peroxide mole-
cules by SOD triggered the CAT enzyme, (ii) isoquercitrin
caused direct activation of CAT enzyme which catalyzed
the toxic hydrogen peroxide to water and oxygen mole-
cules [29,32].ificantly reduced the lipid peroxidation in a dose-dependent manner.
suppressing lipid peroxidation in PC12 cells. Data are mean and S.E.
ntrol cells. **p < 0.01 and ***p < 0.001, relative to cells treated only
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cytoplasm and mitochondria of eukaryotic cells is a vital
antioxidant enzyme that catalyzes the reduction of hydro-
peroxides [33]. In this study, the GPx/Glutathione activity
was also increased by antioxidant treatment. Isoquercitrin
probably interacted with GPx and glutathione to enhance
their antioxidant activity in PC12 cells [21,34]. Malondial-
dehyde (MDA) is a naturally occurring product of lipid
peroxidation that will react with the thiobarbituric acid
(TBA) and form MDA-TBA adducts [35]. Malondialde-
hyde produced due to lipid peroxidation accumulated in
the cells and cause cell damage. MDA increased in 6-
OHDA treated cells and isoquercitrin effectively reduced
the levels of MDA in the pre-treated cells [27-29,32].
Free radicals generated by neurotoxin, 6-hydroxydopamine
caused neuronal cell loss via DNA defects, lipid peroxida-
tion and cytoskeletal disorganization [34]. Moreover, stud-
ies also demonstrated that 6-OHDA induced neuronal loss
was due to inhibition of the mitochondria respiratory chain
complexes I and IV, oxidative phosphorylation uncoupling,
mitochondrial membrane potential collapse [4,22,35,36].
In this study, we have proved that 6-hydoxydopamine in-
duced oxidative stress and cell death by decreasing the
scavenging enzymes (SOD, catalase and GPx) in PC 12
cells. Isoquercitrin pretreatment caused a significant eleva-
tion in these scavenging enzyme levels and attenuate oxi-
dative damage to the cells [22,37,38]. Isoquercitrin helped
to maintain the levels of these antioxidant enzymes and
suppress lipid peroxidation as well as protect the neuronal
cell from undergoing cell death.Conclusions
The results of this study confirmed that neurotoxin 6-
hydroxy dopamine causes suppression of antioxidant en-
zyme levels in PC 12 cells, which could be a reason for the
progressive neuronal death. Isoquercitrin’s role in protect-
ing against 6-OHDA induced oxidative stress, suggests that
this flavonol may serve as a potential neuroprotective agent
against the underlying pathology associated with neurode-
generative diseases like Parkinson’s disease.Methods
Materials
PC12 cells were purchased from ATCC (#CRL-1721.1
PC12 ADH, RattusNorvegicus). 6-hydroxydopamine,
isoquercitrin, poly-L-Lysine, MTT (3-(4,5-Dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide),3,4 – dihydroxy-
L-phenylalanine (Levodopa) and dimethyl sulphoxide
(DMSO) were purchased from Sigma-Aldrich (USA).
Dulbecco’s modified eagle’s medium (DMEM), pen-strep,
horse serum, and fetal bovine serum was purchased
from GIBCO Inc. (USA). Kits for glutathione peroxidase,
superoxide dismutase, catalase, thiobarbiturate assay, andglutathione were purchased from the Cayman Chemical
Company (USA).
Cell culture
PC12 cells were grown in a humidified incubator with
5% CO2 at a temperature of 37°C in DMEM medium
supplemented with 5% horse serum and 5% fetal bovine
serum and pen-step (100 U/ml). The cells were cultured
in poly-L-lysine coated T-75 culture flasks. The cells
used in the experiments were taken between passage 2
and 8 as cells tend to get clumpy and difficult to isolate
after passage 10. When the cells were 80% confluent,
they were dislodged from the flask using a cell scraper.
The dispersed cells were grown on poly-L-lysine coated
96-well microplate at a density of 1 × 105 cells/ml and
allowed overnight incubation to facilitate cell adhesion
to the substrate. The cells were treated for 4, 8 and 12
hours in the presence of isoquercitrin at three different
concentrations, 10 μM, 50 μM and 100 μM. Subsequently,
the pre-treated cells were induced using 6-OHDA for 24
hours and assayed for its antioxidant activities. Control
cells were cultured in complete DMEM alone and positive
control cells were treated only with 6-OHDA.
Determination of cell viability
The cytotoxicity effect of isoquercitrin pretreatment on 6-
OHDA induced PC12 was determined using MTT (3-(4,
5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
assay. MTT, a yellow tetrazole, is reduced to insoluble pur-
ple formazan in the mitochondria of viable cells and ap-
pears purple. The insoluble purple formazan was dissolved
using a solubilizing solvent and the colored solution was
measured at 570 nm using a microplate-reader. Data on
cell viability were expressed as percentage of the surviving
control cell in the study.
Biochemical parameters
Glutathione assay kit utilizes an optimized enzymatic
recycling method that uses glutathione reductase for quan-
tification of GSH. Rate of production of yellow colored 5-
Thio-2-nitrobenzoic acid (TNB) is directly proportional to
the recycling reaction and concentration of glutathione in
the sample. Lipid peroxides, derived from polyunsaturated
fatty acids, are unstable and decompose to form a complex
series of compounds which include reactive carbonyl com-
pounds, such as MDA. MDA-TBA adducts formed by the
reaction of MDA and TBA under high temperature and
acidic conditions is measured colorimetrically at 550 nm.
Super oxide dismutase assay kit utilizes a tetrazolium salt
for the detection of superoxide radicals (O2–) generated
by xanthine oxidase and hypoxanthine. One unit of SOD
is defined as the amount of an enzyme necessary to exhibit
50% dismutation of superoxide radical. Superoxide dis-
mutase levels were determined from a standard curve and
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kit measures GPx activity indirectly by a coupled reac-
tion with glutathione reductase. Oxidized glutathione, pro-
duced upon reduction of an organic hydroperoxide by
GPx, is recycled to its reduced state by glutathione reduc-
tase and NADPH. The oxidation of NADPH to NADP + is
accompanied by a decrease in absorbance at 340 nm.
Glutathione peroxidase levels were determined from a
standard curve and expressed as nmol/min/ml of protein.
The Cayman chemical catalase kit utilizes the peroxidatic
function of catalase for determination of enzyme activity.
The assay is based on the reaction of catalase with metha-
nol in the presence of an optimal concentration of H2O2.
The formaldehyde produced is measured spectrophoto-
metrically with 4-amino-3-hydrazino-5-mercapto-1,2,4-
triazole as the chromogen.
Statistical analysis
Data were expressed as mean ± SEM. The results were an-
alyzed using analysis of variance (ANOVA) using SPSS Inc.
software (SPSS Statistics, V20.0.0). Differences between
treatment groups were determined using the Bonferonni
post-hoc test. A value of P < 0.05 was considered statisti-
cally significant.
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